346
Participants
Start Date
June 30, 2015
Primary Completion Date
March 31, 2017
Study Completion Date
March 31, 2017
gabapentin enacarbil
Horizant Extended Release Tablets, 600 mg, white to off-white, oval shaped tablets, taken 2 times per day
Placebo
Placebo tablet, white to off-white, oval shaped tablets, taken 2 times per day
Mount Sinai St. Luke's Hospital, New York
University of Pennsylvania, Philadelphia
Johns Hopkins University School of Medicine, Baltimore
University of Virginia, Charlottesville
University of Miami, Miller School of Medicine, Miami
The University of Texas Southwestern Medical Center, Dallas
Friends Research Institute, San Francisco
University of California Los Angeles, Los Angeles
Boston University Medical Center, Boston
Dartmouth-Hitchcock Medical Center, Lebanon
Collaborators (1)
Arbor Pharmaceuticals, Inc.
INDUSTRY
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH